Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 735

Results For "RI"

10313 News Found

Sanofi announces change in R&D leadership
People | February 14, 2023

Sanofi announces change in R&D leadership

Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim


Infosys Foundation collaborates with Health Department of Karnataka
Healthcare | February 14, 2023

Infosys Foundation collaborates with Health Department of Karnataka

Through this collaboration, the erstwhile Government Maternity Hospital in Kanakapura Taluk has been rebuilt and the new hospital has facilities including oxygen and medical gas pipelines


FDA approves Pfizer's supplemental new drug application for CIBINQO
Drug Approval | February 14, 2023

FDA approves Pfizer's supplemental new drug application for CIBINQO

Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis


Johnson & Johnson MedTech India partners with Karkinos to upskill professionals in cancer care
Healthcare | February 13, 2023

Johnson & Johnson MedTech India partners with Karkinos to upskill professionals in cancer care

To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform


Govt. improving healthcare and medical education through holistic approach: Dr. Mandaviya
Policy | February 13, 2023

Govt. improving healthcare and medical education through holistic approach: Dr. Mandaviya

Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector


Glenmark Pharma reports Q3 FY 2022-23 revenue growth of 9.2%; PAT growth of 21.3%
News | February 11, 2023

Glenmark Pharma reports Q3 FY 2022-23 revenue growth of 9.2%; PAT growth of 21.3%

Profit After Tax (PAT) for the quarter ended December 31, 2022 was at Rs. 290.8 crore as compared to Rs. 239.8 crore in the previous corresponding quarter, registering a growth of 21.3% YoY


Dishman Carbogen Amcis Q3 FY23 revenue up 14%
News | February 11, 2023

Dishman Carbogen Amcis Q3 FY23 revenue up 14%

The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year


Artificial intelligence facilitates low-cost drug repurposing, says GlobalData
Digitisation | February 11, 2023

Artificial intelligence facilitates low-cost drug repurposing, says GlobalData

The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.


Pfizer appoints Meenakshi Nevatia as MD and Additional Director
People | February 10, 2023

Pfizer appoints Meenakshi Nevatia as MD and Additional Director

She is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and Stryker India Pvt. Ltd.